Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
Video

VIDEO: Ultrasound of tendons detects early rheumatoid arthritis
- Author:
- Jeff Evans
Video

VIDEO: Primary care migraine knowledge needs help
- Author:
- Jeff Evans
News

Lower Diabetes Risk Seen in Lupus Patients Using Hydroxychloroquine
- Author:
- Jeff Evans
Key clinical point: Cumulative HCQ use of at least 129 g may be associated with lower risk of diabetes in patients with lupus and concomitant...
News

Lower diabetes risk seen in lupus patients using hydroxychloroquine
- Author:
- Jeff Evans
Key clinical point: Cumulative HCQ use of at least 129 g may be associated with lower risk of diabetes in patients with lupus and concomitant...
News

Intestinal carbidopa-levodopa gets FDA approval
- Author:
- Jeff Evans
Video

VIDEO: Collaborative clinic aims at heart of CVD prevention in rheumatic diseases
- Author:
- Jeff Evans
Video

VIDEO: No need to stop running for fear of knee osteoarthritis
- Author:
- Jeff Evans
News

VIDEO: No Need to Stop Running for Fear of Knee Osteoarthritis
- Author:
- Jeff Evans
News

Running history doesn’t contribute to knee OA risk
- Author:
- Jeff Evans
Key clinical point: There’s no need to restrict habitual running in people who don’t already have knee OA. Major finding: Symptomatic radiographic...
News

OA patients benefit long term from exercise or manual therapy
- Author:
- Jeff Evans
Key clinical point: Prescribing exercise therapy or manual therapy to patients in various stages of OA can provide long-term benefit in addition...
Video

VIDEO: Exercise, manual therapy for OA add incremental benefits to usual care
- Author:
- Jeff Evans
News

Evidence builds for importance of CVD, new drug targets at ACR
- Author:
- Jeff Evans
News

Disease activity, not lipid levels, appear to affect CV risk with tocilizumab
- Author:
- Jeff Evans
Key clinical point: Disease activity, rather than lipid levels, is an independent predictor of cardiovascular event risk during treatment with...
News

Federal industry foundations partnership for RA, lupus research awards first grants
- Author:
- Jeff Evans
Video

VIDEO: Novel sphingosine 1-phosphate 1 receptor modulator has promising safety results
- Author:
- Jeff Evans